RVNC EV/EBITDA
-3.02
-0.16-5.59%
Sat, 18 Jan 2025 00:53:15 GMT
Summary:
As of January 20, 2025, RVNC EV/EBITDA is -3.02, with a fall of -0.16 (-5.59%) during the most recent trading day. Over the past year, it has increased by +0.06 (+1.95%). RVNC EV/EBITDA is now -48.77% below its all-time high of -2.03.RVNC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -5.6% |
| 1 m1 month | -8.6% |
| 3 m3 months | +16.1% |
| 6 m6 months | +0.3% |
| ytdytd | -9.0% |
| 1 y1 year | +1.9% |
| 5 y5 years | +55.3% |
RVNC EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.77 | -9.0% | -3.02 | at low |
| 3 m | 3-month | -2.75 | -9.8% | -3.90 | +22.6% |
| 6 m | 6-month | -2.66 | -13.5% | -4.04 | +25.3% |
| 1 y | 1-year | -2.03 | -48.8% | -4.04 | +25.3% |
| 3 y | 3-year | -2.03 | -48.8% | -12.34 | +75.5% |
| 5 y | 5-year | -2.03 | -48.8% | -12.34 | +75.5% |
| alltime | all time | -2.03 | -48.8% | -20.50 | +85.3% |
Revance Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.02(+9.0%) |
| 2024 | -2.77(-29.7%) |
| 2023 | -3.94(-42.6%) |
| 2022 | -6.87(+26.8%) |
| 2021 | -5.42(-23.6%) |
| 2020 | -7.09(+56.9%) |
| Date | Value |
|---|---|
| 2019 | -4.52(-7.2%) |
| 2018 | -4.87(-43.6%) |
| 2017 | -8.63(+39.9%) |
| 2016 | -6.17(-43.9%) |
| 2015 | -11.00(+134.5%) |
| 2014 | -4.69 |
FAQ
- What is Revance Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Revance Therapeutics?
- What is RVNC EV/EBITDA year-to-date change?
- What is Revance Therapeutics EV/EBITDA year-on-year change?
What is Revance Therapeutics EV/EBITDA?
The current EV/EBITDA of RVNC is -3.02
What is the all time high EV/EBITDA for Revance Therapeutics?
Revance Therapeutics all-time high EV/EBITDA is -2.03
What is RVNC EV/EBITDA year-to-date change?
Revance Therapeutics EV/EBITDA has changed by -0.25 (-9.03%) since the beginning of the year
What is Revance Therapeutics EV/EBITDA year-on-year change?
Over the past year, RVNC EV/EBITDA has changed by +0.06 (+1.95%)